Bard Memotherm
This article was originally published in The Gray Sheet
Executive Summary
Colorectal stent gains 510(k) clearance for treating malignant obstructions resulting from colon cancer. The self-expanding nitinol device is preloaded on a flexible delivery catheter and endoscopically placed into the colon as a minimally invasive alternative to multi-staged surgery with colostomy to manage patients with bowel obstruction due to malignant growths and strictures. The stent can be used for elective placement to decompress the colon and optimize a patient's condition prior to surgery or for palliative use to avoid colostomy in patients who are not surgical candidates